Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,201 to 2,220 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Longitudinal characterization of biomarkers for spinal muscular atrophy. | Ann Clin Transl Neurol | 2017 | 28491897 | PubTator, text mining | PubMed |
| How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy. | Gene Ther | 2017 | 28485722 | PubTator, text mining | PubMed |
| Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy. | J Med Chem | 2017 | 28481536 | PubTator, text mining | PubMed |
| A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy. | Hum Mol Genet | 2017 | 28460014 | PubTator, text mining | PubMed |
| Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy. | PLoS Genet | 2017 | 28426667 | PubTator, text mining | PubMed |
| Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. | Nature | 2017 | 28405022 | PubTator, text mining | PubMed |
| ISS-N1 makes the First FDA-approved Drug for Spinal Muscular Atrophy. | Transl Neurosci | 2017 | 28400976 | PubTator, text mining | PubMed |
| Cardiac pathology in spinal muscular atrophy: a systematic review. | Orphanet J Rare Dis | 2017 | 28399889 | PubTator, text mining | PubMed |
| Intron retention as a component of regulated gene expression programs. | Hum Genet | 2017 | 28391524 | PubTator, text mining | PubMed |
| Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts. | Neurochem Int | 2017 | 28389270 | PubTator, text mining | PubMed |
| Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease. | Molecules | 2017 | 28379182 | PubTator, text mining | PubMed |
| Newborn screening for spinal muscular atrophy: The views of affected families and adults. | Am J Med Genet A | 2017 | 28374951 | PubTator, text mining | PubMed |
| Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems. | Hum Genet | 2017 | 28374191 | PubTator, text mining | PubMed |
| Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression. | Curr Genomics | 2017 | 28367075 | PubTator, text mining | PubMed |
| Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases. | PLoS Genet | 2017 | 28362802 | PubTator, text mining | PubMed |
| FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides. | Nucleic Acid Ther | 2017 | 28346110 | PubTator, text mining | PubMed |
| First drug to treat spinal muscular atrophy gets FDA approval: Costly injectable shown to stall debilitating muscle-wasting effects of rare genetic disorder. | Am J Med Genet A | 2017 | 28328128 | PubTator, text mining | PubMed |
| An NS-segment exonic splicing enhancer regulates influenza A virus replication in mammalian cells. | Nat Commun | 2017 | 28323816 | PubTator, text mining | PubMed |
| Nusinersen (Spinraza) for spinal muscular atrophy. | Med Lett Drugs Ther | 2017 | 28323809 | PubTator, text mining | PubMed |
| Activation of the intronic cryptic 5' splice site depends on its distance to the upstream cassette exon. | Gene | 2017 | 28322992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=111